Biotron Limited (ASX:BIT)
Australia · Delayed Price · Currency is AUD 0.0020
0.00 (0.00%)
Oct 9, 2026, 4:10 PM AEST
Biotron Market Cap
Biotron has a market cap or net worth of 5.57 million as of October 9, 2026. It is the 45,979th most valuable company in the world and the 1,517th biggest in Australia. Its market cap has increased by 39.90% in one year.
Market Cap
5.57M
Enterprise Value
4.02M
Revenue
525.87K
Global Rank
Country Rank
#1,517 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 19, 2001, Biotron's market cap has decreased from 12.40M to 5.57M, a decrease of -55.08%. That is a compound annual growth rate of -3.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 5.57M | -22.93% |
| Dec 31, 2025 | 7.23M | -55.50% |
| Dec 31, 2024 | 16.24M | -81.44% |
| Dec 29, 2023 | 87.52M | 259.40% |
| Dec 30, 2022 | 24.35M | -64.23% |
| Dec 31, 2021 | 68.09M | 24.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 14.53M |
| AdAlta | 11.24M |
| Invex Therapeutics | 8.27M |
| Bio-Gene Technology | 7.01M |
| Vectus Biosystems | 6.53M |
| Acrux | 6.49M |
| Zelira Therapeutics | 5.95M |
| Tissue Repair | 5.14M |